208 related articles for article (PubMed ID: 28955207)
21. Differential effects of salicylate, quinine, and furosemide on Guinea pig inner and outer hair cell function revealed by the input-output relation of the auditory brainstem response.
Pienkowski M; Ulfendahl M
J Am Acad Audiol; 2011 Feb; 22(2):104-12. PubMed ID: 21463565
[TBL] [Abstract][Full Text] [Related]
22. Cochlear pharmacokinetics of cisplatin: an in vivo study in the guinea pig.
Hellberg V; Wallin I; Ehrsson H; Laurell G
Laryngoscope; 2013 Dec; 123(12):3172-7. PubMed ID: 23754209
[TBL] [Abstract][Full Text] [Related]
23. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition.
Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG
Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286
[TBL] [Abstract][Full Text] [Related]
24. Middle Ear Administration of a Particulate Chitosan Gel in an
Videhult Pierre P; Fransson A; Kisiel MA; Damberg P; Nikkhou Aski S; Andersson M; Hällgren L; Laurell G
Front Cell Neurosci; 2019; 13():268. PubMed ID: 31293387
[TBL] [Abstract][Full Text] [Related]
25. CORM‑2 reduces cisplatin accumulation in the mouse inner ear and protects against cisplatin-induced ototoxicity.
Lyu AR; Jeong Kim S; Jung Park M; Park YH
J Adv Res; 2023 Nov; ():. PubMed ID: 38030129
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
Schweitzer VG
Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
[TBL] [Abstract][Full Text] [Related]
27. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
[TBL] [Abstract][Full Text] [Related]
28. Ototoxicity of the anticancer drug cisplatin. An experimental study.
Nakai Y; Konishi K; Chang KC; Ohashi K; Morisaki N; Minowa Y; Morimoto A
Acta Otolaryngol; 1982; 93(1-6):227-32. PubMed ID: 7199807
[TBL] [Abstract][Full Text] [Related]
29. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
30. Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress.
Qu J; Li X; Wang J; Mi W; Xie K; Qiu J
Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):111-5. PubMed ID: 22055279
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
32. Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in guinea pigs.
Chen BC; Lin LJ; Lin YC; Lee CF; Hsu WC
Acta Otolaryngol; 2022 Feb; 142(2):127-131. PubMed ID: 35287541
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of erdosteine against cisplatin-induced ototoxicity in a guinea pig model.
Waissbluth S; Dupuis I; Daniel SJ
Otolaryngol Head Neck Surg; 2012 Apr; 146(4):627-32. PubMed ID: 22051542
[TBL] [Abstract][Full Text] [Related]
34. Blebs in inner and outer hair cells: a pathophysiological hypothesis.
Ramírez-Camacho R; García-Berrocal JR; Trinidad A; Verdaguer JM; Nevado J
J Laryngol Otol; 2008 Nov; 122(11):1151-5. PubMed ID: 18184450
[TBL] [Abstract][Full Text] [Related]
35. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
Watanabe H; Kanno H
Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
[TBL] [Abstract][Full Text] [Related]
37. The Effects of Riluzole on Cisplatin-induced Ototoxicity.
Üstün Bezgin S; Uygur KK; Gökdoğan Ç; Elmas Ç; Göktaş G
Int Arch Otorhinolaryngol; 2019 Jul; 23(3):e267-e275. PubMed ID: 31360245
[No Abstract] [Full Text] [Related]
38. Pharmacokinetics of sodium thiosulfate in Guinea pig perilymph following middle ear application.
Schroeder RJ; Audlin J; Luo J; Nicholas BD
J Otol; 2018 Jun; 13(2):54-58. PubMed ID: 30559765
[TBL] [Abstract][Full Text] [Related]
39. Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig.
Wang J; Lloyd Faulconbridge RV; Fetoni A; Guitton MJ; Pujol R; Puel JL
Neuropharmacology; 2003 Sep; 45(3):380-93. PubMed ID: 12871655
[TBL] [Abstract][Full Text] [Related]
40. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
